This year's HIPS symposium on 27 and 28 June focused on the fight against antibiotic-resistant pathogens. On the occasion of the tenth anniversary of the HIPS, the expert audience had two days to inform and exchange...
The CRISPR-Cas system is in the spotlight for its ability to precisely modify the DNA of human cells. The system is derived from bacteria that use it to protect themselves from invading viruses. Prof. Peter Fineran...
The accumulation of hazardous waste during manufacturing of complex pharmaceuticals is a serious environmental concern. Typically, it takes several synthetic steps and requires flammable, organic solvents to produce...
Mammalian cells have highly specialized defence programs to protect themselves from invading pathogens. To do this, the cells change the expression of their genes; previously inactive genes are switched on or active...
A delegation of seven researchers from the leading Canadian university McGill recently spent two days at the Helmholtz Centre for Infection Research (HZI) in Braunschweig as part of a working visit. HZI and McGill...
An influenza vaccination causes the body to form antibodies that circulate in the blood, but which are directed against constantly changing virus components. This means that the vaccine must be re-administered each...
The Centre for Individualised Infection Medicine (CiiM) is continuing to gain structure and establishment is progressing rapidly. Since summer 2019, this has been accompanied by the new dual leadership of CiiM directors...
For a long time, itaconic acid was only known as a metabolic product of fungi. Its function was unknown, but for decades it has been used industrially for polymer production. In 2013, it was surprisingly discovered as...
Ascenion GmbH, technology transfer partner of the Helmholtz Centre for Infection Research (HZI), announces the take-over of its portfolio company WBC Drug Delivery Technologies (WBC) by Klaria Pharma Holding AB in an...